Long-term study on rheumatoid arthritis in remission
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study follows patients with rheumatoid arthritis who are in remission to see how they do over the long term. It may help doctors understand the best way to manage the disease over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have taken part in the ARCTIC REWIND trial before.
- You need to be able to understand and agree to the study procedures.
- You should not have any serious mental health or substance abuse problems that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medical device to help people with rheumatoid arthritis stay in remission while on biologic therapy. The goal is to see if the device can prevent flares and maintain disease control.
This study follows people who are at high risk for developing rheumatoid arthritis, as well as first-degree relatives of RA patients and people with very early untreated RA. It aims to learn more about the disease so doctors can better predict and prevent it.
This study follows people with rheumatoid arthritis (RA) who have achieved remission—meaning their disease is well-controlled—to see how safely doctors can reduce or stop their medications over time. You would be monitored regularly to ensure your RA stays in remission.
This study looks at people with adult rheumatoid arthritis to see how long biological medicines and “JAK inhibitors” keep helping. It uses routine clinic follow-up records to understand how well treatment persists over time and how outcomes change.
This study is observing people with a hard-to-treat form of rheumatoid arthritis (RA). Researchers want to understand what treatments and outcomes are like for people whose RA doesn't get better with standard medications like methotrexate.
This study looks at what causes disease flares in people with rheumatoid arthritis. Researchers will track participants to find predictors of flare-ups, which could help manage the disease better.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.